$Tesla Motors(TSLA)$  $NVIDIA(NVDA)$  $Netflix(NFLX)$  🚀📊🧠 Liquidity Is Leading, Not Breadth 📈⚡🚀 I’m reading this market through one primary lens right now, liquidity is leading price, not participation. That distinction matters, especially into a holiday week where surface-level calm can hide very deliberate positioning underneath. 📈 Mega-cap options concentration sets the regime I’m looking at the 10-day options volume leaderboard and $NVDA remains miles ahead with roughly 45.9M contracts traded. That level of sustained activity reflects institutional scale an

The GLP1 thing is scary, the get-thin-fast trend is biting into the inner fears that people have of their bodies. I have seen so many people look emaciated and sallow (if I had to guess, this is the problem of the 2 big names of the Wicked movie franchise) GLP1 can be a good thing especially for the obese and the diabetic, but not controlling it properly is a huge problem. Preying on people's insecurity to make big money is not the way to go. And seriously, the competition would only heat up, with Eli Lilly making their own jab, Chinese companies producing cheap knockoffs, and the companies in the US that stepped up production when Novo could not keep up with demand. If we are really looking at Novo to go further, I question their viability for the long term.

Wall Street ended higher fueled by a sizzling tech rally and soft inflation data easing economic worries, with S&P 500 climbing 0.6% to 6,878.49 for its third straight winning day. Tech gains continued with Micron rising 10% to $115 on blowout earnings forecasts from booming AI market, memory demand tripling from Nvidia's H200 frenzy – Q1 rev $9.05B up 18% crushes if beats land, unlocking $130 highs as semis rebound. Tesla, Nvidia jump about 1% each to $446.74 and $140.50, riding Optimus buzz and open-source AI models adding $5B ecosystem rev by 2027. Trump Media soars 42% to $45 on political surge and media dominance, riding tariff thaw whispers for 20% more gains if ad rev hits $100M Q4. US core CPI eased to four-year low in shutdown-hit report, cooling yields to 3.75% and locking Fe

Global markets are on edge as the US Dollar Index (DXY) teeters at a critical 15-year support zone, sparking wild debates on what's next for currencies, stocks, and commodities. As of December 23, 2025, the DXY sits at 96.718 after a sharp drop from its overvalued highs earlier this year, touching a trendline that's held firm since 2010. This level's been tested multiple times in recent months, with pressure building from foreign central banks tightening policy and the Fed easing amid rising US debt costs. Large trade and fiscal deficits don't resolve with a strong dollar – history shows adjustments come through financial repression, easier with a weaker currency. If this support shatters, capital flows reverse, risk appetite flips, and assets reprice across the board. Hard assets like gol

Microsoft has been consolidating near 485 USD with a slight dip, while Apple slipped below 271 USD and NVIDIA showed strength with a rebound to 183 USD. My view this week is that NVIDIA remains the most compelling short-term play given its momentum and sector tailwinds, while Microsoft offers stability for those preferring defensive exposure. Apple’s weakness could be an opportunity if you believe in its longer-term ecosystem resilience, but near-term sentiment looks cautious. Personally, I see NVIDIA as the stock with the best tactical upside this week, though I treat gains as incremental rather than outsized. Did I make money? Yes, but modestly—taking disciplined profits on NVIDIA’s bounce while keeping Microsoft as a core holding.

My top stock in focus today is $Novo-Nordisk A/S(NVO)$ after U.S. regulators approved the first GLP-1 weight-loss pill, an oral version of Ozempic and Wegovy. The pill is set to launch in the U.S. in early January at $149 per month, potentially expanding access beyond injection-based treatments. Oral GLP-1 drugs are expected to capture about 25% of the projected $150 billion obesity market, appealing to patients who prefer pills over injections. Novo Nordisk’s tablet showed strong efficacy, with patients losing an average of 16.6% of body weight in trials, supporting semaglutide’s clinical strength. For Novo Nordisk, the Wegovy pill offers a critical first-mover

Hi，Tigers：💰Did you make any money? Share your thoughts!🎯Catch up fast：These events rocked the markets today.More NewsTiger Community TOP10 Tickers🎯 S&P500 Most Active Today 👉@TigerObserverWeekly Five Key Areas: Macro, Singapore Stocks, Options, Futures, EarningsCovering five major market segments this week to help you stay ahead of market trends and plan your trades effectively!✨Tuesday — Singapore StocksSingapore stocks opened flat on Tuesday.CapitaLand Investment (CLI): Bursa-listed CapitaLand Malaysia Trust (CLMT) has agreed to buy five high-specification industrial facilities in the Johor-Singapore Special Economic Z

For week ending 19 Dec 2025, US market had been interesting. It had a mixed performance but laced with bullish momentum. On Wed, 17 Dec 2025, both S&P 500 and Nasdaq were still below their 50-day lines as ORCL continued to weigh on AI stocks. Before the week was over, they managed to reclaim their 50-day & 21-day lines as MU earnings and tame CPI inflation, buoyed markets. This resulted in leading stocks faring well, with many flashing buy signals, notably sectors in the tech, medical, aerospace and travel. One of the tech stocks termed a “Buy” by Wall Street analysts is $Palantir Technologies Inc.(PLTR)$, which has an interesting run in 2025, looking back. PLTR Retrospect. Historically, PLTR has had a phenomenal run in the last 1½ year. I

$Bumitama Agri(P8Z.SI)$ 1.8 Target Price with 6.5% Dividend Yield. Bumitama Agri's stock outlook looks promising, with analysts predicting a positive trend. The company's share price is expected to rise over the next 12 months, with an average price target of SGD1.79, representing a 18% upside from the current price of SGD1.25 *Key Highlights:* - *Revenue Growth*: Bumitama Agri is expected to achieve double-digit revenue growth, driven by healthy orders from key customers. - *Dividend Yield*: The company offers a dividend yield of 2.9%, with a history of increasing dividend payments. - *Analyst Ratings*: Bumitama Agri has a Strong Buy consensus rating, with analysts from Maybank Research, DBS Research, and UOB Kay Hian maintaining a Buy rating.

Options Market Statistics: Nvidia Surges 1.5% as Major H200 AI Chip Shipment to China Takes Shape $NVIDIA(NVDA)$   ranked second in options activity with a neutral put/call ratio of 0.49 and a low IV rank of 2.86%, indicating subdued volatility bets as volume hit 1.64 million contracts against 16.92 million in open interest. Shares gained 1.5% following Reuters reports that the company intends to deliver between 40,000 and 80,000 H200 AI processors to China, with insiders noting initial batches could arrive before the Lunar New Year.   $Tesla Motors(TSLA)$   led overall volume with a neutral put/call ratio of 0.61

There have been huge support seen on $SoFi Technologies Inc.(SOFI)$, the current support is now at previous resistance highs from 2021 and 2022. We can see that SOFI bulls have been putting up a very good fight every time we challenge this range. We can see that the 12-month EMA is casually curling up. I think we can make this area on a technical standpoint. So if we looking for the monthly higher lows for more upside movement in 2026, we can see that trading is decent around 27 or lower. and not forgetting that SOFI PEG is at 1.1 and SoFi's (SOFI) Price-to-Sales (P/S) ratio varies slightly by source but generally hovers around 9.9x to 10x for the current trailing twelve months (TTM), with some estimates showing it as high as 11.91x, indicating in

$Rocket Lab USA, Inc.(RKLB)$ $AST SpaceMobile, Inc.(ASTS)$  $Northrop Grumman(NOC)$  🚀📉🧠 Rocket Lab, after-hours price action versus information 🧠📉🚀 I’m watching the after-hours tape in Rocket Lab and the move doesn’t align with the underlying information. The stock is down roughly $5 in after-hours trade following reports that a director sold 30,000 shares last week. 📊 Insider activity in context The filings show 30k shares sold across December under a pre-arranged 10b5-1 plan. Post-sale, the director still owns approximately 393,000 shares. On a ~$20B market capitalisation, this transaction

Market Overview Global markets delivered a mixed performance. Wall Street extended its winning streak for a third straight session, driven mainly by renewed optimism in AI-related sectors. Asian equities also strengthened on hopes of further US rate cuts and easing concerns around AI spending. In contrast, European markets drifted lower as holiday-thin volumes kept investors cautious. Wall Street Extends Rally US markets closed higher with solid gains: • Dow Jones +227.79 pts to 48,362.68 • S&P 500 +43.99 pts to 6,878.49 This marks the third consecutive winning day as AI enthusiasm continued to support sentiment, while broader economic resilience helped sustain bullish momentum. Europe Pauses Ahead of Holidays European equities remained muted as trading activity slowed heading into the

$Amazon.com(AMZN)$ remains a good stock for options trading due to its strong underlying business fundamentals, analyst optimism and growth potential in high-margin sectors, and stock volatility that provides trading opportunities. In this article, I would like to share my options-trading–oriented analysis of why Amazon (AMZN) remains a compelling stock for options traders based on strong fundamentals, volatility dynamics, and market sentiment: Robust Underlying Business Fundamentals A solid fundamental backdrop tends to support informed options trading because it reduces the likelihood of unpredictable, catastrophic moves while still providing directional catalysts. Key long-term drivers: a. AWS leadership and profitability Amazon Web Services (A

U.S. Stocks with Heavy Trading / Momentum These names are active or getting attention in market screens (volume, price moves, news): • Tesla (TSLA) – often trending due to news flow and high trading volume.  • Broadcom (AVGO) – featured among most active stocks.  • NVIDIA (NVDA) – big tech/AI favorite often among top traded names.  • Apple (AAPL) – regularly in the most-active list. 

$Advanced Micro Devices(AMD)$  $Oracle(ORCL)$  $Western Digital(WDC)$  I want to focus on a volatility screen that highlights structural mispricing rather than headline noise. This is not a list of volatile stocks. It is a list of stocks where options have been historically underpriced relative to the actual realised moves in the underlying. The attached table ranks stocks by Volatility Scorecard, with most names clustered between 96 and 100. That immediately tells me implied volatility has repeatedly failed to reflect realised volatility, not occasionally, but ac

The iShares Silver Trust (SLV) has seen positive developments today, with its stock price rising by 2.32% to $62.345, and trading volume reaching 31.94 million shares. The ETF's holdings have also increased, with its latest reported holdings at 16,066.24 tons of silver, marking a significant rise and reflecting strong investor interest in silver 56. Key Highlights: Price Performance: Current Price: $62.345 (+2.32%). 52-Week High: $62.82. Trading Volume: 31.94M shares. Holdings Growth: The ETF's silver holdings have surged to 16,066.24 tons, a three-and-a-half-year high, indicating robust demand for silver 26. Market Sentiment: The ETF's performance aligns with broader gains in silver-related assets, such as silver miners and other silver ETFs 13. Capital Flow: Recent capital inflows sugges

All look good

Chillax